Biosimilar of Remicade Market, Global Outlook and Forecast 2024-2030 || https://lnkd.in/dH72nwZV
The global Biosimilar of Remicade market was valued at US$ 282010 million in 2023 and is projected to reach US$ 473740 million by 2030, at a CAGR of 7.6% during the forecast period.
Market segment by Type:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market segment by Application:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Major players covered:
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly and Company
Novartis
Merck Group
3SBio Inc.
Changchun High & New Technology Industry (Group) Inc.
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
#biosimilarremicade #biosimilar #remicade #vaccine #healthcare #biosimilarremicademarketreport #biosimilarremicademarketgrowth #24marketresearch
